Cardiorespiratory Fitness and Body Composition Responses to Different Intensities and Frequencies of Exercise Training in Colorectal Cancer Survivors
Overview
Oncology
Authors
Affiliations
Introduction: Deteriorations in cardiorespiratory fitness (V˙o) and body composition are associated with poor prognosis after colorectal cancer treatment. However, the optimal intensity and frequency of aerobic exercise training to improve these outcomes in colorectal cancer survivors is unknown.
Patients And Methods: This trial compared 8 weeks of moderate-intensity continuous exercise (MICE; 50 minutes; 70% peak heart rate [HR]; 24 sessions), with high-intensity interval exercise (HIIE; 4 × 4 minutes; 85%-95% HR) at an equivalent (HIIE; 24 sessions) and tapered frequency (HIIE-T; 16 sessions) on V˙o and on lean and fat mass, measured at baseline, 4, 8, and 12 weeks.
Results: Increases in V˙o were significantly greater after both 4 (+3.0 mL·kg·min, P = .008) and 8 (+2.3 mL·kg·min, P = .049) weeks of HIIE compared to MICE. After 8 weeks, there was a significantly greater reduction in fat mass after HIIE compared to MICE (-0.7 kg, P = .038). Four weeks after training, the HIIE group maintained elevated V˙o (+3.3 mL·kg·min, P = .006) and reduced fat mass (-0.7 kg, P = .045) compared to the MICE group, with V˙o in the HIIE-T also being superior to the MICE group (+2.8 mL·kg·min, P = .013).
Conclusion: Compared to MICE, HIIE promotes superior improvements and short-term maintenance of V˙o and fat mass improvements. HIIE training at a reduced frequency also promotes maintainable cardiorespiratory fitness improvements. In addition to promoting accelerated and superior benefits to the current aerobic exercise guidelines, HIIE promotes clinically relevant improvements even with a substantial reduction in exercise training and for a period after withdrawal.
Brouwer C, Tusscher M, de Roos B, Gootjes E, Buffart T, Versteeg K Support Care Cancer. 2025; 33(2):82.
PMID: 39779537 PMC: 11711133. DOI: 10.1007/s00520-024-09101-1.
Machado P, Paixao A, Oliveiros B, Martins R, Cruz J Support Care Cancer. 2024; 33(1):20.
PMID: 39663237 PMC: 11635004. DOI: 10.1007/s00520-024-09069-y.
Dias-da-Silva Jr G, Panissa V, Derchain S, Ferreira M, Telles G, Buzaglo G Sports Med. 2024; .
PMID: 39602033 DOI: 10.1007/s40279-024-02145-7.
Santos A, Braaten K, MacPherson M, Vasconcellos D, Vis-Dunbar M, Lonsdale C Int J Behav Nutr Phys Act. 2023; 20(1):134.
PMID: 37990239 PMC: 10664287. DOI: 10.1186/s12966-023-01535-w.
Neuendorf T, Haase R, Schroeder S, Schumann M, Nitzsche N Support Care Cancer. 2023; 31(12):643.
PMID: 37851104 PMC: 10584719. DOI: 10.1007/s00520-023-08103-9.